Skip to main content
. 2021 May 22;2021(5):CD012721. doi: 10.1002/14651858.CD012721.pub3

ChiCTR‐TRC‐09000631.

Study name Treatment of diastolic heart failure: the role of blockade of the renin‐angiotensin system. A comparison of diuretics with an angiotensin converting enzyme inhibitor, angiotensin receptor blockade or diuretics alone
Methods Study design:
Anticipated completion date:
Participants Estimated enrolment: 450
Inclusion criteria:
"1. Signed informed consent;
2. Age >18 yrs;
3. history of heart failure for 2 months prio to screening;
4. NYHA Functional Class II‐IV;
5. LV EF >45% by ECHO or a radionucleotide technique;
6. Therapy with diuretics with stable dose >14 days prior to screening"
Exclusion criteria:
"1. NHYA class I;
2. Inability to answer the QOL questionnaire;
3. Myocardial infarction within 3 months;
4. unstable angina within 1 month;
5. Significant cardiac valvular heart disease;
6. Hypotension SBP <90 mmHg;
7. uncontrolled hypertension(DBP>105 ors SBP> 200 mmHg);
8. uncontrolled serious cardiac arrhythmias associated with a ventricular rate >100 bpm at study entry;
9. concurrent therapy with CCB, Betablocker, ACEI, AII or positive inotropic agents other than digoxin for control of AF"
Interventions Ramipril + Diuretics vs. Irbesartan +Diuretics vs. Diuretics alone (comparison diuretics + irbesartan versus diuretics of interest to this review)
Outcomes Hospital admissions for heart failure or mortality; quality of life assessed by the Minnesota Quality of life Questionnaire; exercise duration assessed by 6 min corridor walk test; side‐effects, effect on levels of natriuretic peptides, effect on doppler‐echocardiographic derived measurements of left ventricular diastolic function
Starting date 13 July 1997
Contact information Skiva Chan: skivachan@cuhk.edu.hk
Notes Recruitment status: completed